Related Experiment Video
Updated: Jan 31, 2026

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy
Published on: June 25, 2013
Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy
David J Zahavi1, Louis M Weiner2
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Medical Center, 3800 Reservoir Rd NW, Washington, DC 20007, USA. djz8@georgetown.edu.
Abstract:
Immune checkpoint blockade therapy is a powerful treatment strategy for many cancer types. Many patients will have limited responses to monotherapy targeted to a single immune checkpoint. Both inhibitory and stimulatory immune checkpoints continue to be discovered. Additionally, many receptors previously identified to play a role in tumor formation and progression are being found to have immunomodulatory components. The success of immunotherapy depends on maximizing pro-anti-tumor immunity while minimizing immunosuppressive signaling. Combining immune checkpoint targeted approaches with each other or with other receptor targets is a promising schema for future therapeutic regimen designs.
Insights
Immune checkpoint blockade therapy shows promise for cancer treatment. Combining therapies targeting multiple immune checkpoints or other receptors may improve patient responses and anti-tumor immunity.
Area of Science:
- Immunology
- Oncology
- Cancer Therapeutics
Background:
- Immune checkpoint blockade therapy is a significant advancement in cancer treatment.
- Many patients exhibit limited responses to single immune checkpoint inhibitors.
- Ongoing discovery of novel inhibitory and stimulatory immune checkpoints, alongside immunomodulatory roles of known receptors, highlights therapeutic complexity.
Purpose of the Study:
- To explore strategies for enhancing anti-tumor immunity.
- To investigate the potential of combining immune checkpoint inhibitors.
- To assess the combination of immune checkpoint blockade with other receptor-targeted therapies.
Main Methods:
- Review of current immune checkpoint blockade therapies.
- Analysis of emerging inhibitory and stimulatory immune checkpoints.
- Evaluation of immunomodulatory functions of receptors in cancer progression.
Main Results:
- Monotherapy targeting a single immune checkpoint often yields limited patient responses.
- Discoveries of new immune checkpoints and receptor functions expand therapeutic targets.
- Maximizing pro-anti-tumor immunity while minimizing immunosuppression is key to immunotherapy success.
Conclusions:
- Combining immune checkpoint targeted approaches offers a promising therapeutic strategy.
- Integration with other receptor targets may further enhance treatment efficacy.
- Future therapeutic regimens should consider combination strategies for improved cancer immunotherapy outcomes.
Related Concept Videos
Neuromuscular Junction And Blockade
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Self-Efficacy
Increasing Function
Internal Receptors
Increased Body Temperature

